IPO Challenges, including Musinsa and Dalba
While K-beauty and fashion brands stand out in the global market, related companies are also listed.
This week, the vegan beauty brand Dalbaglobe, famous for its “crew mist,” will start a general subscription on the 9th, and the beauty medical company BioBizu will start a general subscription on the 8th.
According to the securities industry on the 6th, Dalba Global will complete its demand forecast for institutional investors by the 7th and proceed with general subscriptions from the 9th to the 12th.
Based on the desired public offering price, the expected market capitalization is 657.8 billion won to 80.2 billion won. Attention is being paid to whether it will be able to turn around the market atmosphere with mid- to large-sized initial public offerings (IPOs) following DN Solutions and Lotte Global Logistics, which recently withdrew from listing.
Founded in 2016, Dalba Global is a beauty brand with a high proportion of exports and is highly praised for securing a global consumer base.
It has been increasing brand awareness in the United States, Japan, and Southeast Asia with its functional cosmetics “Dalba Mist.”
About 70% of the total sales come from overseas, and it quickly succeeded in entering the global market through social network service (SNS)-based digital marketing and product promotion strategies for airline crew members.
BioBiz, a cosmetic medical company that has been successful in the demand forecast, will also hold a general subscription from the 8th to the 9th.
Previously, BioBizu recorded a competition ratio of 1094.25 to 1 in the demand forecast for institutional investors conducted from the 23rd to the 29th of last month, confirming the public offering price at 9,100 won, the upper end of the desired range. After listing, the expected market capitalization is around 136.9 billion won.
Founded in 2018, BioBizu is a company that develops and produces beauty medical products such as skin boosters, hyaluronic acid (HA) fillers, and medical cosmetics.
It has its own brands such as Candorub, Asenart, and Corena. The public offering funds will be invested in the expansion of the second plant and R&D. When the second plant is completed, the company plans to convert medical cosmetics currently under consignment production into their own production.
In addition, domestic beauty and fashion companies that are expanding their influence by targeting the global market are being listed this year.
AU Brands, which went public in April, is a company that has grown by rebranding its rainboot brand “Rockfish” as “Rockfish Weatherware.”
Despite the slowing initial public offering (IPO) market last month, the stock price also closed higher on the first day of listing following demand forecasts and general subscription box office success, attracting investors’ attention.
Mimibox also selected Samsung Securities as its host last year and is preparing to go public. The company operates brands such as ‘I’m Mimi’ and ‘Kaja’.
It generates more than 90% of its total sales abroad, and its growth in the North American market is remarkable.
Musinsa, one of the largest fashion platforms in Korea, is also expected to visualize its listing, including the selection of the organizer this year. Although no official listing plan has been announced yet, the market evaluates it as a strong candidate for a trillion-dollar public offering.
Meanwhile, a total of three new companies will enter the KOSDAQ market this week.
Now Robotics, a company specializing in intelligent robots, will be listed on the 8th. The company provides a one-stop solution based on its ability to build and develop robot automation systems such as orthogonal robots, multi-joint robots, Scara robots (horizontal multi-joint robots), and autonomous logistics robots.
On the 9th, eco-friendly energy solution company OneILTI and bio company Organoid Science will be listed on KOSDAQ side by side.
In the liquefied natural gas (LNG) sector, 1ILTI is exclusively supplying “BOG Recondenser” in Korea, which mixes boil-off gas with LNG and re-liquefies, and in the hydrogen sector, it is expanding its business focusing on hydrogen storage alloy mass production technology.
It also runs a hydrogen reformer-related business that extracts hydrogen from natural gas.
Organoid Science is a bio-company based on ‘organoid (organ mimic)’ technology.
Organoids are the cultivation of tissues similar to human organs based on stem cell technology. It has great value in developing regenerative agents and new drug test tools.
The company’s main products are the organoid regeneration treatment ‘Atom’ and the new material evaluation solution ‘Odisei’.
link
